Last Updated on May 11, 2024 by The Health Master
Regulators
To empower regulators at both central and state levels, a groundbreaking virtual initiative has been launched: The CDSCO-WHO-BRIC THSTI Regulatory Webinar Series.
Joint Effort for Regulatory Excellence
This series is a collaborative effort between leading organizations:
- Central Drugs Standard Control Organisation (CDSCO): India’s national regulatory body for drugs and cosmetics.
- World Health Organization (WHO) India Country Office: The WHO’s branch dedicated to supporting India’s health agenda.
- Biotechnology Research Innovation Council (BRIC): A government body promoting biotechnology research and innovation.
- Translational Health Science and Technology Institute (THSTI): A premier institute fostering advancements in translational research.
This collaboration signifies a commitment to building a robust regulatory framework in India.
Equipping Regulators with Essential Skills
Inaugurated on May 1st, 2024, the webinar series offers a comprehensive curriculum focused on four crucial regulatory areas:
- Good Regulatory Practices (GRPs) in Medical Product Regulation: This module equips regulators with best practices for effective and efficient drug regulation.
- Guidelines for Good Review Practices (GVP): Participants gain expertise in meticulously evaluating drug applications to ensure product safety and efficacy.
- Quality Management System (QMS) Requirements for Inspectorates: This module focuses on establishing robust QMS for regulatory inspections, ensuring consistency and compliance.
- WHO Guidelines on QMS Implementation: Regulators learn the best practices for implementing and maintaining effective QMS within their organizations.
A Self-Paced Learning Journey
The CDSCO-WHO-BRIC THSTI Regulatory Webinar Series is designed for a self-paced learning experience.
This flexibility allows regulators to fit the training into their busy schedules, maximizing their learning potential.
Investing in Regulatory Excellence
This webinar series is a significant step towards strengthening India’s pharmaceutical regulatory landscape.
By equipping regulators with the necessary knowledge and skills, the initiative paves the way for a more efficient, effective, and robust regulatory system, ultimately benefiting public health and patient safety.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Empowering Regulators for Excellence: 21 Training Programs in 2024-25
CDSCO Empowers Regulators, Drives Pharma Export Boom
Regulatory Landscape for Medical Device Companies in India
Regulatory Control to Combat the Menace of Spurious / Counterfeit Drugs
The proposal for a Unified Drug Regulatory Authority in India
Regulator’s Guide: Mastering the Art of Effective Drug Sample Collection for Analysis
Key Notes on Revised Schedule M: Must read
Important short notes for Industry and Regulators
CDSCO Guidelines on Drug Recall
Quality Assurance Vs Quality Control in the Pharma Industry
Major FDA audit findings about Equipment and Instruments
Understanding GMP, cGMP, and WHO-GMP
Quality Assurance in the Pharmaceutical Industry
Duties and responsibilities of QA person in Pharma Industry
Difference: Disintegration and Dissolution test in pharma industry
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
Codeine Phosphate and its Regulations in India
Laboratory Waste Management, Types and Its Disposal
How to Become a Skilled Manufacturing Chemist in the Pharma Industry
FSSAI: Food Labelling and Display – Chapter-1
Gist of 31 Chapters on Schedule M
Drug Export NOCs Now Handled by CDSCO
USFDA Approval granted for Acetaminophen and Ibuprofen Tablets
Drug recall: This Dietary Supplement recalled due to the Presence of Nortadalafil
DCA Telangana raids crack down on Mislabeled Medicines
Is the Drugs and Magic Remedies Act Outdated ?
USFDA approval granted for Loteprednol Etabonate Eye Drops
Proposed Sale of OTC Drugs in General Stores Raises Concerns from Chemists
Empowering Regulators for Excellence: 21 Training Programs in 2024-25
USFDA inspection: With OAI observations at Sun Pharma
Specific Regulations required for New Drugs and Clinical Trial Rules for Homoeopathy
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
